Skip to main content
Clinical Trials/NCT05064241
NCT05064241Active, not recruitingNot Applicable

Investigations of Barriers and Methods to Overcome Barriers to Access Genetic Medicine

Boston Children's Hospital1 site in 1 country70 target enrollmentStarted: April 15, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
70
Locations
1
Primary Endpoint
Qualitative self-report of referrals for clinical genetic services

Study Overview

Brief Summary

To learn about patient barriers to accessing genetic medicine, we will analyze anonymous posts from a membership-based online community [Inspire.com], and investigate how these barriers differ for various populations. We will then test whether these barriers can be addressed by providing online access to a genetic counselor to answer patient questions for one group of patients (virtual advisory board group) and compare to that of a control group who does not have access to a genetic counselor (virtual peer-to-peer board group).

Detailed Description

Genomic medicine has the potential to advance diagnoses, predict risk, support prevention efforts, and inform treatment decision-making. Though technologies for measuring genetic variants have improved and become more cost-effective, clinical integration of genomic medicine has been surprisingly slow. For genomic medicine to be successfully implemented across specialties and across demographics, the systemic barriers that patients experience need to be identified and addressed.

Online health support is becoming an increasingly important part of healthcare as more patients use digital health networks. In the first part of this study, an analysis of online communication in a membership-based online support community [Inspire.com] will identify systemic, structural and individual barriers to accessing genomic medicine. A genetic counselor will be informed to these results and will be part of the intervention arm of the study.

To assess the extent to which online health networks can directly help genomic medicine implementation, participants will join one of two Virtual Discussion Boards (a Virtual Advisory Board and a Virtual Peer-to-Peer Discussion Board). In the intervention arm, the Virtual Advisory Board will have a genetic counselor answer patient questions online about genomic medicine once every week for a period of three months. In the control arm, participants will answer and comment on each others' questions in the Virtual Peer-to-Peer Discussion Board. We hypothesize that after six months, patients who participate in the Virtual Advisory Board are more likely to self-report receiving genomic medicine than those in the control arm. After completion of the study, participants in the Peer-to-Peer Discussion Board, we will give online access to the genetic counselor to answer any questions

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Participant)

Masking Description

Participants will not be told which discussion board they are randomized to. However, they may possibly discover that one board has a genetic counselor, and the other does not.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Member of Inspire.com Genetic disease Genetic predisposition to disease -

Exclusion Criteria

  • •Not member of Inspire.com No genetic disease No genetic predisposition to disease

Arms & Interventions

Virtual Advisory Board

Experimental

Participants have access to a genetic counselor to answer their questions on accessing genetic medicine.

Intervention: Access to Genetic Counselor for answering questions (Other)

Virtual Peer-to-Peer Discussion Board

No Intervention

Participants answer each others' questions on the topic of accessing genetic medicine.

Outcomes

Primary Outcomes

Qualitative self-report of referrals for clinical genetic services

Time Frame: 6 months

Percentage of participants with self-report of referrals for clinical genetic services

Secondary Outcomes

  • Self-report of specific behaviors to overcome barriers to accessing genetic medicine(6 months)
  • Qualitative self-report of specific barriers to the participant accessing genomic medicine(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Catherine Brownstein

Assistant Professor

Boston Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials